Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Wednesday, March 4, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Authors
Posts by Life Sciences Times
Life Sciences Times
8044 POSTS
0 Comments
https://blstimes.com
Public Health
WHO chief calls for more investments in public health
Life Sciences Times
-
December 28, 2020
0
Public Health
This condition makes it hard for people to draw a mental picture
Life Sciences Times
-
December 28, 2020
0
Public Health
European nations begin Covid-19 vaccinations
Life Sciences Times
-
December 28, 2020
0
Pharma
India’s first fully indigenous pneumococcal vaccine launched
Life Sciences Times
-
December 28, 2020
0
Public Health
COVAXX and Aurobindo Pharma Announce COVID-19 Vaccine Partnership
Life Sciences Times
-
December 24, 2020
0
Real Estate
Franklin Street Properties Corp. Announces the Sale of 4820 Emperor Boulevard in Durham, North Carolina for $89.7 Million
Life Sciences Times
-
December 24, 2020
0
Public Health
Pfizer and BioNTech to Supply the U.S. with 100 Million Additional Doses of COVID-19 Vaccine
Life Sciences Times
-
December 23, 2020
0
Pharma
Innovative drug, Carrimycin, Receives FDA Approval for International, Multi-country Phase III Clinical Trial for the treatment of severe COVID-19 in hospitalized patients
Life Sciences Times
-
December 23, 2020
0
Pharma
Skincare company dupes Instagram creators into buying products
Life Sciences Times
-
December 23, 2020
0
Pharma
US sues Walmart for ‘fueling’ opioid crisis in the country
Life Sciences Times
-
December 23, 2020
0
1
...
792
793
794
...
805
Page 793 of 805
TOP AUTHORS
Life Sciences Times
8044 POSTS
0 Comments
https://blstimes.com
Most Read
Mobile Heartbeat Expands Banyan Platform Integration With Microsoft Teams to Improve Enterprise Communication
March 3, 2026
Syntis Bio Doses First Patient in Phase 1/1b Trial of Oral Obesity Drug SYNT-101, Expands Leadership Team
March 3, 2026
Poplar Therapeutics Raises $45 Million to Advance Anti-IgE Therapy for Food Allergy and Atopic Diseases
March 3, 2026
Amylyx Pharmaceuticals Narrows Losses in 2025 as Phase 3 Avexitide Trial Nears Completion
March 3, 2026